Reviewed by the HeyPsych Medical Review Board
Board-certified psychiatrists and mental health professionals
Clinical summary for Quetiapine (Seroquel): Quetiapine (Seroquel) can help with bipolar mood episodes, schizophrenia symptoms, and can be added to antidepressants for major depression. It can also be used off-label for anxiety or insomnia in select cases. Biggest tradeoffs: sleepiness, dizziness/low blood pressure, and metabolic changes (weight, cholesterol, blood sugar). It is not approved for dementia-related psychosis because antipsychotics increase death risk in that group.
Quetiapine can feel wildly different depending on dose and what you’re treating (sleep/anxiety vs mood/psychosis). Here’s what people commonly describe:
Sedation / “Knocked out” sleepiness
"It helped me sleep… but it also hit me like a truck."
Quetiapine has two timelines: sedation can show up fast, while the real psychiatric benefits typically build over days to weeks depending on what you’re treating and the dose you’re using.
Quetiapine is used for schizophrenia and bipolar disorder (mania and bipolar depression). It can also be used as an add-on for major depression when an antidepressant alone isn’t enough. Off-label, it’s sometimes used for anxiety or insomnia in select cases—usually when there’s a psychiatric reason that makes the risk/benefit make sense.
Quetiapine strongly blocks histamine (H1) receptors, which can cause heavy sedation—especially at lower-to-moderate doses and early in treatment. For some people, that’s the point (sleep), but for others it becomes the reason they quit (daytime fog, oversleeping).
It’s not a controlled substance and it doesn’t cause the classic addiction pattern like benzodiazepines or opioids. But your body can adapt to it, and stopping abruptly can cause rebound insomnia, anxiety, agitation, and symptom return. So it’s not “no consequences”—it’s more “not a drug of abuse in the usual way.”
Yes, it can. Quetiapine is known for increasing appetite and causing weight gain in a meaningful number of people, and it can also worsen triglycerides, cholesterol, and blood sugar. This is why baseline and follow-up metabolic monitoring isn’t optional—it’s part of safe prescribing.
It can raise blood sugar and increase the risk of new-onset diabetes in some people, especially with longer exposure and with other risk factors. Monitoring fasting glucose or HbA1c (and acting early if numbers change) is how you reduce harm.
It depends on why it’s being used. In older adults with dementia-related psychosis, antipsychotics increase the risk of death and quetiapine is not approved for that use. For conditions like schizophrenia or bipolar disorder, it may still be used in older adults—but usually at lower doses with slower titration and closer monitoring for falls, low blood pressure, sedation, and metabolic changes.
Quetiapine has a dose-related QTc prolongation risk that’s usually modest but can become clinically important in people with risk factors (baseline QT prolongation, low potassium/magnesium, heart disease, interacting meds, overdose). If you’ve had fainting, palpitations, or you’re on QT-prolonging meds, ask about ECG monitoring.
Sometimes—but it’s not a casual sleep med. If you have bipolar disorder, severe anxiety, or another psychiatric condition where quetiapine is pulling double duty, sleep benefit may be part of the plan. If the only problem is insomnia, the metabolic and cardiovascular tradeoffs often outweigh the benefit, especially long-term.
Most people should taper rather than stopping abruptly—especially after long-term use. A gradual reduction helps avoid rebound insomnia/anxiety and lets you catch early relapse symptoms. If you’re stopping because of a serious adverse effect, the plan should be guided urgently by a clinician.
It can be used in pregnancy or breastfeeding when clinically indicated, but it should be individualized. In pregnancy, the big issues are relapse risk if you stop treatment and metabolic monitoring (including gestational diabetes screening as part of routine prenatal care). In breastfeeding, reported infant exposure is generally low, but infants should be monitored for sedation or feeding issues—especially if premature or if other sedatives are involved.
This treatment information is for educational purposes only. Treatment decisions should be made in consultation with qualified healthcare professionals based on individual circumstances, symptoms, and medical history. Do not attempt treatment without professional guidance.
This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.